Skip to Content



PDF options:  View Fullscreen   Download PDF

PDF Transcript


Quinagolide Tablets
Norprolac® Tablets
Patient Information

Read all of this leaflet carefully before you start taking this medicine.
• Keep this leaflet, you may need to use it again.
• If you have further questions, please ask your doctor or pharmacist.
• This medicine has been prescribed for you personally and you should not pass it on to others. It may
harm them, even if their symptoms are the same as yours.
In this leaflet:
1. What Quinagolide is and what it is used for
2. Before you take Quinagolide
3. How to take Quinagolide
4. Possible side effects
5. How to store Quinagolide
6. Further information
1. What Quinagolide is and what it is used for
Quinagolide is for oral use only. It is available in strengths of 25 micrograms, 50 micrograms and 75
micrograms. Quinagolide contains quinagolide which decreases the production of the hormone prolactin.
Quinagolide is used to treat conditions resulting from high levels of prolactin in the blood
(hyperprolactinaemia) including:
• excess production of breast milk
• changes in menstrual bleeding patterns
• infertility
• reduced sexual drive.
2. Before you take Quinagolide
Do not take Quinagolide:
• if you have a medical condition affecting your liver or kidneys
• if you are allergic to any of the ingredients listed in section 6
If you are pregnant or planning a pregnancy, please refer to the pregnancy section of this leaflet.
Before taking Quinagolide:
• please consult your doctor if you have ever had any mental illness.
• Quinagolide may cause your blood pressure to drop when you stand up, particularly for the first few
days of treatment or following an increase in your dosage. This may result in reduced alertness or
fainting. To avoid this, stand up slowly from a sitting or lying down position. Your doctor will normally
check your blood pressure during the first few days of treatment and when increasing your dosage.
• Inform your doctor if you or your family/carer notices that you are developing urges or cravings to
behave in ways that are unusual for you and you cannot resist the impulse, drive or temptation to carry
out certain activities that could harm yourself or others. These are called impulse control disorders and
can include behaviours such as addictive gambling, excessive eating or spending, an abnormally high sex
drive or an increase in sexual thoughts or feelings. Your doctor may need to adjust or stop your dose.
Taking/using other medicines:
Please inform your doctor or pharmacist if you are taking or have recently taken or used any other
medicines - even those not prescribed.
Taking Quinagolide with drink:
Drinking alcohol may increase the side effects of Quinagolide. If this happens, you should avoid drinking
alcohol while you are on treatment with Quinagolide.

• Fertility may be restored while you are on Quinagolide, so women of child-bearing age who do not wish
to become pregnant should use a reliable method of contraception.
• If you are planning a pregnancy, it is recommended that Quinagolide is stopped when pregnancy is
confirmed. However, some patients may need to continue treatment with Quinagolide during pregnancy.
If you become pregnant while you are on Quinagolide, tell your doctor as soon as possible.
Quinagolide reduces production of breast-milk, so it is not normally possible to breast-feed while you are
taking it. You should not breast-feed even if it is possible to do so. This is because it is not known
whether the active ingredient in Quinagolide passes into breast-milk.
Driving and using machines:
While you are on Quinagolide, caution is advised if you drive or operate machinery. This is because
• may cause your blood pressure to drop, particularly during the first few days of treatment or following
dosage increase. This may result in reduced alertness or fainting.
• may also cause somnolence (drowsiness or sleepiness).
If you experience any of these effects, please do not drive or engage in any other activity (e.g. operating
machinery) where impaired alertness may put you or others at risk of serious injury or death and please
consult your doctor, as your dose may need to be adjusted.
Important information about some of the ingredients in Quinagolide:
Quinagolide contains the ingredient lactose. Therefore, if you have been told by your doctor that you have
an intolerance to some sugars (including lactose), contact your doctor before taking this medicinal
3. How to take Quinagolide
It is important to take your medicine as directed by your doctor. The label on your medicine should tell
you how much to take and when to take it. If it does not, or you are not sure, ask your doctor or
Take this medicine only if your doctor has decided that this is appropriate for you. Follow the instructions
given to you very carefully.
The tablets should only be removed from the blister when it is time to take your medicine.
• Your treatment will normally begin with the ‘starter pack’ and you will take one 25 micrograms tablet
daily (one light pink tablet) for the first three days (marked Day 1, Day 2 and Day 3 on the blister strip).
• This is followed by one 50 micrograms tablet daily (one very pale blue tablet) for the next three days
(marked Day 4, Day 5 and Day 6 on the blister strip).
• From Day 7, the recommended dose is one 75 micrograms tablet daily (one whitish tablet). Most
patients require a daily dose of 75 to 150 micrograms. Some patients require a daily dose of 300
micrograms or higher. Your doctor will tell you if you need a higher dose. You should not change the
dose yourself.
Quinagolide should be taken once daily at bedtime preferably with a snack. Remove the tablet from the
blister by pushing it through the foil and place it in your mouth. Swallow it with a mouthful of water.
If you take more Quinagolide than you should:
If you take more Quinagolide than you should, tell your doctor immediately or go to your nearest casualty
If you forget to take Quinagolide:
If you forget to take a dose, take it as soon as you remember. However, if you do not remember until it is
nearly time for the next dose, take your next dose as usual and carry on as before. Do not take double
doses to make up for a dose that you miss.

. Possible side effects
Like all medicines, Quinagolide can have side effects. These are most common during the first few days
of treatment and tend to go away on continuing treatment.
Very common side effects (affect more than 10 of every 100 patients treated):
• Nausea
• Vomiting
• Headache
• Dizziness
• Tiredness
Common side effects (affect between 1 and 10 of every 100 patients treated):
• Loss of appetite
• Abdominal pain
• Constipation or diarrhoea
• Insomnia
• Increased water retention
• Flushing
• Nasal congestion and a drop in blood pressure, which may result in fainting.
Rare side effects (affect between 1 and 10 of every 10,000 patients treated):
• Somnolence (drowsiness or sleepiness).
Very rare side effects (affect less than 1 of every 10,000 patients treated):
• Treatment with Quinagolide has been associated with a change in mental status, which is reversible
when treatment is stopped.
Other side effects include:
Inability to resist the impulse, drive or temptation to perform an action that could be harmful to you or
others, which may include:
• strong impulse to gamble excessively despite serious personal or family consequences.
• altered or increased sexual interest and behaviour of significant concern to you or to others, for example,
an increased sexual drive.
• uncontrollable excessive shopping or spending.
• binge eating (eating large amounts of food in a short time period) or compulsive eating (eating more
food than normal and more than is needed to satisfy your hunger).
Tell your doctor if you experience any of these behaviours; they will discuss ways of managing or
reducing the symptoms.
Reporting of side effects
If you get any side effects, talk to your doctor or pharmacist or nurse. This includes any possible side
effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme
( By reporting side effects you can help provide more information on the
safety of this medicine.
5. Storing Quinagolide
Keep Quinagolide out of the reach and sight of children.
Do not store above 25ºC.
Do not take the tablets past the expiry date on the packaging.
If you are unsure about the storage, ask your pharmacist. It is best to return all old and unused medicines
to your pharmacist for safe disposal.
6. Further information
Your medicine is called Quinagolide Tablets. They are for oral use only.
• Quinagolide contains the active ingredient, quinagolide (as quinagolide hydrochloride). It is available in
strengths of 25 micrograms, 50 micrograms and 75 micrograms quinagolide.

• Quinagolide also contains: colloidal anhydrous silica, methylhydroxypropylcellulose, maize starch,
magnesium stearate, microcrystalline cellulose and lactose. In addition, the 25 microgram tablets contain
indigotin lake as colouring agents.
• Treatment usually starts with a ‘starter pack’ containing 3 tablets of 25 micrograms (light pink) and 3
tablets of 50 micrograms (very pale blue) in a single blister strip. This is then followed by treatment with
75 micrograms (whitish) tablets presented in a pack of 30 tablets in blister strips of 10 tablets per strip.
Marketing Authorisation Holder:
Aspire Pharma Ltd., Unit 4 Rotherbrook Court, Bedford Road, Petersfield, Hampshire, GU32 3QG, UK
Ferring GmbH, Wittland 11,D-24109 Kiel,Germany.
Quinagolide Tablets 25 micrograms PL 35533/0062
Quinagolide Tablets 50 micrograms PL 35533/0063
Quinagolide Tablets 75 micrograms PL 35533/0064
This leaflet was last revised in September 2016.

+ Expand Transcript

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.